{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:05:06Z","timestamp":1773407106249,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008089","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000}}],"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Short QT (SQT) syndrome is a genetic cardiac disorder characterized by an abbreviated QT interval of the patient\u2019s electrocardiogram. The syndrome is associated with increased risk of arrhythmia and sudden cardiac death and can arise from a number of ion channel mutations. Cardiomyocytes derived from induced pluripotent stem cells generated from SQT patients (SQT hiPSC-CMs) provide promising platforms for testing pharmacological treatments directly in human cardiac cells exhibiting mutations specific for the syndrome. However, a difficulty is posed by the relative immaturity of hiPSC-CMs, with the possibility that drug effects observed in SQT hiPSC-CMs could be very different from the corresponding drug effect\n                    <jats:italic>in vivo<\/jats:italic>\n                    . In this paper, we apply a multistep computational procedure for translating measured drug effects from these cells to human QT response. This process first detects drug effects on individual ion channels based on measurements of SQT hiPSC-CMs and then uses these results to estimate the drug effects on ventricular action potentials and QT intervals of adult SQT patients. We find that the procedure is able to identify IC\n                    <jats:sub>50<\/jats:sub>\n                    values in line with measured values for the four drugs quinidine, ivabradine, ajmaline and mexiletine. In addition, the predicted effect of quinidine on the adult QT interval is in good agreement with measured effects of quinidine for adult patients. Consequently, the computational procedure appears to be a useful tool for helping predicting adult drug responses from pure\n                    <jats:italic>in vitro<\/jats:italic>\n                    measurements of patient derived cell lines.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1008089","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T17:21:31Z","timestamp":1613496091000},"page":"e1008089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4234-9094","authenticated-orcid":true,"given":"Karoline Horgmo","family":"J\u00e6ger","sequence":"first","affiliation":[]},{"given":"Samuel","family":"Wall","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-146X","authenticated-orcid":true,"given":"Aslak","family":"Tveito","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"2","key":"pcbi.1008089.ref001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047299","article-title":"Idiopathic short QT interval: a new clinical syndrome?","volume":"94","author":"I Gussak","year":"2000","journal-title":"Cardiology"},{"key":"pcbi.1008089.ref002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcvm.2018.00149","article-title":"Recent advances in short QT syndrome","volume":"5","author":"O Campuzano","year":"2018","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"pcbi.1008089.ref003","first-page":"401","article-title":"Short QT syndrome: from bench to bedside","volume":"3","author":"C Patel","year":"2010","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"8","key":"pcbi.1008089.ref004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT syndrome: a familial cause of sudden death","volume":"108","author":"F Gaita","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"pcbi.1008089.ref005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cardiores.2005.03.026","article-title":"Short QT syndrome","volume":"67","author":"R Schimpf","year":"2005","journal-title":"Cardiovascular Research"},{"issue":"1","key":"pcbi.1008089.ref006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"R Brugada","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"pcbi.1008089.ref007","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/jce.12204","article-title":"\u03b2-Blockers in Congenital Short-QT Syndrome as Ion Channel Blockers","volume":"24","author":"H Abriel","year":"2013","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"24","key":"pcbi.1008089.ref008","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jacc.2017.10.025","article-title":"Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome","volume":"70","author":"A Mazzanti","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"pcbi.1008089.ref009","doi-asserted-by":"crossref","first-page":"e007394","DOI":"10.1161\/JAHA.117.007394","article-title":"Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes","volume":"7","author":"I El-Battrawy","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"23","key":"pcbi.1008089.ref010","doi-asserted-by":"crossref","first-page":"e010073","DOI":"10.1161\/JAHA.118.010073","article-title":"Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome","volume":"7","author":"I El-Battrawy","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"pcbi.1008089.ref011","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cpt.1449","article-title":"Drug Testing in Human-Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1","volume":"106","author":"Z Zhao","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"8","key":"pcbi.1008089.ref012","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment","volume":"43","author":"F Gaita","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"pcbi.1008089.ref013","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2005.02.018","article-title":"Modulation of IKr inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome","volume":"67","author":"J Cordeiro","year":"2005","journal-title":"Cardiovascular Research"},{"issue":"2","key":"pcbi.1008089.ref014","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2005.06.112","article-title":"The N588K-HERG K+ channel mutation in the\u2019short QT syndrome\u2019: mechanism of gain-in-function determined at 37\u00b0C","volume":"334","author":"MJ McPate","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"pcbi.1008089.ref015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1540-8167.2005.04470.x","article-title":"Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG","volume":"16","author":"C Wolpert","year":"2005","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"4","key":"pcbi.1008089.ref016","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"K Takahashi","year":"2006","journal-title":"Cell"},{"issue":"12","key":"pcbi.1008089.ref017","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced Pluripotent Stem Cells 10 Years Later","volume":"120","author":"Y Yoshida","year":"2017","journal-title":"Circulation Research"},{"issue":"6","key":"pcbi.1008089.ref018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cells7060048","article-title":"Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications","volume":"7","author":"A Di Baldassarre","year":"2018","journal-title":"Cells"},{"issue":"5","key":"pcbi.1008089.ref019","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12265-018-9811-3","article-title":"The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing","volume":"11","author":"L Ye","year":"2018","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"pcbi.1008089.ref020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.05.004","article-title":"Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair","volume":"96","author":"ME Hartman","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"pcbi.1008089.ref021","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.118.311209","article-title":"Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes as Models for Cardiac Channelopathies","volume":"123","author":"P Garg","year":"2018","journal-title":"Circulation Research"},{"issue":"1","key":"pcbi.1008089.ref022","doi-asserted-by":"crossref","first-page":"17626","DOI":"10.1038\/s41598-018-35858-7","article-title":"Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems","volume":"8","author":"A Tveito","year":"2018","journal-title":"Scientific Reports"},{"key":"pcbi.1008089.ref023","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fphar.2019.01648","article-title":"Improved computational identification of drug response using optical measurements of human stem cell derived cardiomyocytes in microphysiological systems","volume":"10","author":"KH J\u00e6ger","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"pcbi.1008089.ref024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41540-018-0047-2","article-title":"Population-based mechanistic modeling allows for quantitative predictions of drug responses across cell types","volume":"4","author":"JQ Gong","year":"2018","journal-title":"NPJ Systems Biology and Applications"},{"issue":"21","key":"pcbi.1008089.ref025","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1111\/bph.13282","article-title":"Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block","volume":"172","author":"M Paci","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"pcbi.1008089.ref026","doi-asserted-by":"crossref","first-page":"e1002061","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation","volume":"7","author":"T O\u2019Hara","year":"2011","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"pcbi.1008089.ref027","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2009.09.019","article-title":"A novel computational model of the human ventricular action potential and Ca transient","volume":"48","author":"E Grandi","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2-3","key":"pcbi.1008089.ref028","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbiomolbio.2009.01.010","article-title":"Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium","volume":"98","author":"MM Maleckar","year":"2008","journal-title":"Progress in Biophysics and Molecular Biology"},{"issue":"1","key":"pcbi.1008089.ref029","doi-asserted-by":"crossref","first-page":"H301","DOI":"10.1152\/ajpheart.1998.275.1.H301","article-title":"Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model","volume":"275","author":"M Courtemanche","year":"1998","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"11","key":"pcbi.1008089.ref030","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s10439-013-0833-3","article-title":"Computational models of ventricular-and atrial-like human induced pluripotent stem cell derived cardiomyocytes","volume":"41","author":"M Paci","year":"2013","journal-title":"Annals of Biomedical Engineering"},{"key":"pcbi.1008089.ref031","article-title":"A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources","author":"DC Kernik","year":"2019","journal-title":"The Journal of Physiology"},{"issue":"1","key":"pcbi.1008089.ref032","doi-asserted-by":"crossref","first-page":"H56","DOI":"10.1152\/ajpheart.00270.2006","article-title":"In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes","volume":"292","author":"S Vecchietti","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"pcbi.1008089.ref033","article-title":"Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to anti-arrhythmic pharmacological therapy: an in silico approach","author":"M Paci","year":"2017","journal-title":"Heart Rhythm"},{"key":"pcbi.1008089.ref034","volume-title":"A bi-domain model for describing ischemic myocardial dc potentials","author":"L Tung","year":"1978"},{"issue":"5","key":"pcbi.1008089.ref035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.81.5.727","article-title":"Ionic mechanisms of propagation in cardiac tissue: roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling","volume":"81","author":"RM Shaw","year":"1997","journal-title":"Circulation Research"},{"issue":"1","key":"pcbi.1008089.ref036","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.110.223610","article-title":"Whole-heart modeling: Applications to cardiac electrophysiology and electromechanics","volume":"108","author":"NA Trayanova","year":"2011","journal-title":"Circulation Research"},{"key":"pcbi.1008089.ref037","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphy.2017.00048","article-title":"A cell-based framework for numerical modeling of electrical conduction in cardiac tissue","volume":"5","author":"A Tveito","year":"2017","journal-title":"Frontiers in Physics"},{"issue":"5","key":"pcbi.1008089.ref038","doi-asserted-by":"crossref","first-page":"e1007042","DOI":"10.1371\/journal.pcbi.1007042","article-title":"Properties of cardiac conduction in a cell-based computational model","volume":"15","author":"KH J\u00e6ger","year":"2019","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1008089.ref039","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphys.2012.00346","article-title":"Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias","volume":"3","author":"M Hoekstra","year":"2012","journal-title":"Frontiers in Physiology"},{"issue":"3","key":"pcbi.1008089.ref040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.vascn.2014.09.005","article-title":"Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents","volume":"70","author":"JK Gibson","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"5","key":"pcbi.1008089.ref041","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2018.1470621","article-title":"Emerging therapeutic targets in the short QT syndrome","volume":"22","author":"JC Hancox","year":"2018","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"pcbi.1008089.ref042","doi-asserted-by":"crossref","unstructured":"Paci M, Passini E, Klimas A, Severi S, Hyttinen J, Rodriguez B, et al. In silico populations optimized on optogenetic recordings predict drug effects in human induced pluripotent stem cell-derived cardiomyocytes. In: 2018 Computing in Cardiology Conference (CinC). vol. 45. IEEE; 2018. p. 1\u20134.","DOI":"10.22489\/CinC.2018.086"},{"issue":"5","key":"pcbi.1008089.ref043","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1529\/biophysj.104.047449","article-title":"A mathematical treatment of integrated Ca dynamics within the ventricular myocyte","volume":"87","author":"TR Shannon","year":"2004","journal-title":"Biophysical Journal"},{"issue":"4","key":"pcbi.1008089.ref044","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A simplex method for function minimization","volume":"7","author":"JA Nelder","year":"1965","journal-title":"The Computer Journal"},{"key":"pcbi.1008089.ref045","unstructured":"MATLAB Global Optimization Toolbox; Version 4.3."},{"issue":"8","key":"pcbi.1008089.ref046","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.RES.0000016960.61087.86","article-title":"Ionic current basis of electrocardiographic waveforms: a model study","volume":"90","author":"K Gima","year":"2002","journal-title":"Circulation Research"},{"issue":"5","key":"pcbi.1008089.ref047","doi-asserted-by":"crossref","first-page":"H1577","DOI":"10.1152\/ajpheart.00936.2009","article-title":"Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk","volume":"298","author":"E Pueyo","year":"2010","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"12","key":"pcbi.1008089.ref048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002313","article-title":"Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome","volume":"7","author":"I Adeniran","year":"2011","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"pcbi.1008089.ref049","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12938-017-0369-0","article-title":"Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study","volume":"16","author":"C Luo","year":"2017","journal-title":"Biomedical Engineering Online"},{"issue":"4","key":"pcbi.1008089.ref050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4161\/chan.24905","article-title":"In silico assessment of drug safety in human heart applied to late sodium current blockers","volume":"7","author":"B Trenor","year":"2013","journal-title":"Channels"},{"key":"pcbi.1008089.ref051","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncom.2017.00027","article-title":"An evaluation of the accuracy of classical models for computing the membrane potential and extracellular potential for neurons","volume":"11","author":"A Tveito","year":"2017","journal-title":"Frontiers in Computational Neuroscience"},{"issue":"2","key":"pcbi.1008089.ref052","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1113\/jphysiol.1977.sp011672","article-title":"The actions of ouabain on intercellular coupling and conduction velocity in mammalian ventricular muscle","volume":"264","author":"R Weingart","year":"1977","journal-title":"The Journal of Physiology"},{"key":"pcbi.1008089.ref053","unstructured":"National Center for Biotechnology Information. PubChem Database. Quinidine, CID = 441074;. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Quinidine."},{"key":"pcbi.1008089.ref054","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fphar.2019.00771","article-title":"Impact of antiarrhythmic drugs on the outcome of Short QT Syndrome","volume":"10","author":"I El-Battrawy","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"s2","key":"pcbi.1008089.ref055","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.eupc.2005.04.008","article-title":"Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall","volume":"7","author":"DL Weiss","year":"2005","journal-title":"EP Europace"},{"key":"pcbi.1008089.ref056","unstructured":"Bartolucci C, Moreno C, de la Cruz A, Lambiase P, Severi S, Valenzuela C. Linking a novel mutation to its short QT phenotype through multiscale computational modelling. In: Computing in Cardiology 2014. IEEE; 2014. p. 1017\u20131020."},{"issue":"23","key":"pcbi.1008089.ref057","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1088\/0031-9155\/51\/23\/014","article-title":"Cell model for efficient simulation of wave propagation in human ventricular tissue under normal and pathological conditions","volume":"51","author":"KH ten Tusscher","year":"2006","journal-title":"Physics in Medicine and Biology"},{"issue":"1","key":"pcbi.1008089.ref058","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0033583506004227","article-title":"Computational biology in the study of cardiac ion channels and cell electrophysiology","volume":"39","author":"Y Rudy","year":"2006","journal-title":"Quarterly Reviews of Biophysics"},{"issue":"1896","key":"pcbi.1008089.ref059","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1098\/rsta.2008.0301","article-title":"Markov models for ion channels: versatility versus identifiability and speed","volume":"367","author":"M Fink","year":"2009","journal-title":"Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences"},{"issue":"1","key":"pcbi.1008089.ref060","first-page":"H66","article-title":"Pharmacogenetics and anti-arrhythmic drug therapy: A theoretical investigation","volume":"292","author":"CE Clancy","year":"2007","journal-title":"AJP: Heart and Circulatory Physiology"},{"issue":"3","key":"pcbi.1008089.ref061","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3934\/mbe.2011.8.861","article-title":"Defining candidate drug characteristics for Long-QT (LQT3) syndrome","volume":"8","author":"A Tveito","year":"2011","journal-title":"Mathematical Biosciences and Engineering"},{"key":"pcbi.1008089.ref062","doi-asserted-by":"crossref","unstructured":"Tveito A, Lines GT. Computing Characterizations of Drugs for Ion Channels and Receptors Using Markov Models. Springer-Verlag, Lecture Notes, vol. 111; 2016.","DOI":"10.1007\/978-3-319-30030-6"},{"key":"pcbi.1008089.ref063","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3389\/fphys.2017.00759","article-title":"Computational analysis of the mode of action of disopyramide and quinidine on hERG-linked short QT syndrome in human ventricles","volume":"8","author":"DG Whittaker","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"pcbi.1008089.ref064","doi-asserted-by":"crossref","unstructured":"Luo C, Wang K, Liu T, Zhang H. Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles. In: 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE; 2018:5462\u20135465.","DOI":"10.1109\/EMBC.2018.8513572"},{"issue":"1","key":"pcbi.1008089.ref065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08367-2","article-title":"In silico investigation of a KCNQ1 mutation associated with short QT syndrome","volume":"7","author":"I Adeniran","year":"2017","journal-title":"Scientific Reports"},{"key":"pcbi.1008089.ref066","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1038\/srep08883","article-title":"Human iPSC-based cardiac microphysiological system for drug screening applications","volume":"5","author":"A Mathur","year":"2015","journal-title":"Scientific Reports"},{"key":"pcbi.1008089.ref067","doi-asserted-by":"crossref","first-page":"e36717","DOI":"10.7554\/eLife.36717","article-title":"The Ca2+ transient as a feedback sensor controlling cardiomyocyte ionic conductances in mouse populations","volume":"7","author":"CM Rees","year":"2018","journal-title":"eLife"},{"issue":"9","key":"pcbi.1008089.ref068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000914","article-title":"Regression analysis for constraining free parameters in electrophysiological models of cardiac cells","volume":"6","author":"AX Sarkar","year":"2010","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1008089.ref069","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.569489","article-title":"Identifying drug response by combining measurements of the membrane potential, the cytosolic calcium concentration, and the extracellular potential in microphysiological systems","volume":"11","author":"KH J\u00e6ger","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"pcbi.1008089.ref070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02887804","article-title":"Effect of tetrodotoxin on the transmembrane potential of the pacemaker cell in the sinus venosus of toad","volume":"8","author":"Q Wen-ning","year":"1988","journal-title":"Journal of Tongji Medical University"},{"issue":"11","key":"pcbi.1008089.ref071","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1113\/jphysiol.2011.223313","article-title":"Exploiting mathematical models to illuminate electrophysiological variability between individuals","volume":"590","author":"AX Sarkar","year":"2012","journal-title":"The Journal of Physiology"},{"issue":"2-3","key":"pcbi.1008089.ref072","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pbiomolbio.2004.02.002","article-title":"Parameter estimation in cardiac ionic models","volume":"85","author":"S Dokos","year":"2004","journal-title":"Progress in Biophysics and Molecular Biology"},{"issue":"7","key":"pcbi.1008089.ref073","doi-asserted-by":"crossref","first-page":"073102","DOI":"10.1063\/1.5087629","article-title":"Detecting undetectables: Can conductances of action potential models be changed without appreciable change in the transmembrane potential?","volume":"29","author":"KH J\u00e6ger","year":"2019","journal-title":"Chaos: An Interdisciplinary Journal of Nonlinear Science"},{"issue":"4","key":"pcbi.1008089.ref074","doi-asserted-by":"crossref","first-page":"e001813","DOI":"10.1161\/JAHA.115.001813","article-title":"hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine","volume":"4","author":"D Melgari","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"pcbi.1008089.ref075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2005.100776","article-title":"Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels","volume":"572","author":"A Bucchi","year":"2006","journal-title":"The Journal of Physiology"},{"key":"pcbi.1008089.ref076","doi-asserted-by":"crossref","first-page":"36","DOI":"10.33594\/000000119","article-title":"Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels","volume":"53","author":"N Haechl","year":"2019","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"6","key":"pcbi.1008089.ref077","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjp.2008.325","article-title":"Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs","volume":"155","author":"M McPate","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"pcbi.1008089.ref078","doi-asserted-by":"crossref","first-page":"138a","DOI":"10.1016\/j.bpj.2013.11.807","article-title":"Sensitivity of Flecainide Inhibition of hERG Channels to Channel Inactivation","volume":"106","author":"D Melgari","year":"2014","journal-title":"Biophysical Journal"},{"issue":"3","key":"pcbi.1008089.ref079","first-page":"311","article-title":"Effect of ajmaline on action potential and ionic currents in rat ventricular myocytes","volume":"24","author":"M B\u00e9barov\u00e1","year":"2005","journal-title":"General Physiology and Biophysics"},{"issue":"1","key":"pcbi.1008089.ref080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(81)90317-4","article-title":"Comparatibe actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle","volume":"74","author":"KR Courney","year":"1981","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"pcbi.1008089.ref081","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/toxsci\/kfv128","article-title":"Proarrhythmia risk assessment in human induced pluripotent stem cell-derived cardiomyocytes using the maestro MEA platform","volume":"147","author":"Y Qu","year":"2015","journal-title":"Toxicological Sciences"},{"issue":"5","key":"pcbi.1008089.ref082","first-page":"415","article-title":"DDPH inhibited L-type calcium current and sodium current in single ventricular myocyte of guinea pig","volume":"22","author":"XD Hu","year":"2001","journal-title":"Acta pharmacologica Sinica"},{"issue":"1","key":"pcbi.1008089.ref083","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"GR Mirams","year":"2011","journal-title":"Cardiovascular Research"},{"issue":"3","key":"pcbi.1008089.ref084","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF02888208","article-title":"Relationship between action potential duration of ventricular cells and heart rate in dog under natural breathing","volume":"7","author":"T Ming","year":"1987","journal-title":"Journal of Tongji Medical University"},{"issue":"3","key":"pcbi.1008089.ref085","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1476-5381.2012.02200.x","article-title":"Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials","volume":"168","author":"N Zemzemi","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"pcbi.1008089.ref086","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00791-003-0100-5","article-title":"Modeling the electrical activity of the heart: a bidomain model of the ventricles embedded in a torso","volume":"5","author":"GT Lines","year":"2003","journal-title":"Computing and Visualization in Science"},{"issue":"7","key":"pcbi.1008089.ref087","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11517-009-0472-x","article-title":"Cardiac anisotropy in boundary-element models for the electrocardiogram","volume":"47","author":"M Potse","year":"2009","journal-title":"Medical & Biological Engineering & Computing"},{"issue":"3","key":"pcbi.1008089.ref088","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10439-009-9873-0","article-title":"Mathematical modeling of electrocardiograms: a numerical study","volume":"38","author":"M Boulakia","year":"2010","journal-title":"Annals of Biomedical Engineering"},{"issue":"3","key":"pcbi.1008089.ref089","doi-asserted-by":"crossref","first-page":"H1038","DOI":"10.1152\/ajpheart.00679.2005","article-title":"Isolation and characterization of IKr in cardiac myocytes by Cs+ permeation","volume":"290","author":"S Zhang","year":"2006","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"5","key":"pcbi.1008089.ref090","doi-asserted-by":"crossref","first-page":"e1002061","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation","volume":"7","author":"T O\u2019Hara","year":"2011","journal-title":"PLoS Computational Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008089","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T13:48:48Z","timestamp":1614347328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008089"}},"subtitle":[],"editor":[{"given":"Daniel A.","family":"Beard","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008089","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.24.168690","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}